Global OTC Pet Medication Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by OTC Pet Medication Revenue
• 1.4 Market by Type
  • 1.4.1 Global OTC Pet Medication Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Fleas & Ticks Removal
  • 1.4.3 Pain Relief & Arthritis
  • 1.4.4 Dewormers
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global OTC Pet Medication Market Share by Application: 2020 VS 2026
  • 1.5.2 Dogs & Cats
  • 1.5.3 Birds
  • 1.5.4 Fish & Reptiles
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global OTC Pet Medication Market Perspective (2015-2026)
• 2.2 Global OTC Pet Medication Growth Trends by Regions
  • 2.2.1 OTC Pet Medication Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 OTC Pet Medication Historic Market Share by Regions (2015-2020)
  • 2.2.3 OTC Pet Medication Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 OTC Pet Medication Market Growth Strategy
  • 2.3.6 Primary Interviews with Key OTC Pet Medication Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top OTC Pet Medication Players by Market Size
  • 3.1.1 Global Top OTC Pet Medication Players by Revenue (2015-2020)
  • 3.1.2 Global OTC Pet Medication Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global OTC Pet Medication Market Concentration Ratio
  • 3.2.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by OTC Pet Medication Revenue in 2019
• 3.3 OTC Pet Medication Key Players Head office and Area Served
• 3.4 Key Players OTC Pet Medication Product Solution and Service
• 3.5 Date of Enter into OTC Pet Medication Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global OTC Pet Medication Historic Market Size by Type (2015-2020)
• 4.2 Global OTC Pet Medication Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global OTC Pet Medication Market Size by Application (2015-2020)
• 5.2 Global OTC Pet Medication Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America OTC Pet Medication Market Size (2015-2020)
• 6.2 OTC Pet Medication Key Players in North America (2019-2020)
• 6.3 North America OTC Pet Medication Market Size by Type (2015-2020)
• 6.4 North America OTC Pet Medication Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe OTC Pet Medication Market Size (2015-2020)
• 7.2 OTC Pet Medication Key Players in Europe (2019-2020)
• 7.3 Europe OTC Pet Medication Market Size by Type (2015-2020)
• 7.4 Europe OTC Pet Medication Market Size by Application (2015-2020)

8 China

• 8.1 China OTC Pet Medication Market Size (2015-2020)
• 8.2 OTC Pet Medication Key Players in China (2019-2020)
• 8.3 China OTC Pet Medication Market Size by Type (2015-2020)
• 8.4 China OTC Pet Medication Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan OTC Pet Medication Market Size (2015-2020)
• 9.2 OTC Pet Medication Key Players in Japan (2019-2020)
• 9.3 Japan OTC Pet Medication Market Size by Type (2015-2020)
• 9.4 Japan OTC Pet Medication Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia OTC Pet Medication Market Size (2015-2020)
• 10.2 OTC Pet Medication Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia OTC Pet Medication Market Size by Type (2015-2020)
• 10.4 Southeast Asia OTC Pet Medication Market Size by Application (2015-2020)

11 India

• 11.1 India OTC Pet Medication Market Size (2015-2020)
• 11.2 OTC Pet Medication Key Players in India (2019-2020)
• 11.3 India OTC Pet Medication Market Size by Type (2015-2020)
• 11.4 India OTC Pet Medication Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America OTC Pet Medication Market Size (2015-2020)
• 12.2 OTC Pet Medication Key Players in Central & South America (2019-2020)
• 12.3 Central & South America OTC Pet Medication Market Size by Type (2015-2020)
• 12.4 Central & South America OTC Pet Medication Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Bayer Companion Animal
  • 13.1.1 Bayer Companion Animal Company Details
  • 13.1.2 Bayer Companion Animal Business Overview
  • 13.1.3 Bayer Companion Animal OTC Pet Medication Introduction
  • 13.1.4 Bayer Companion Animal Revenue in OTC Pet Medication Business (2015-2020))
  • 13.1.5 Bayer Companion Animal Recent Development
• 13.2 Boehringer Ingelheim Animal Health
  • 13.2.1 Boehringer Ingelheim Animal Health Company Details
  • 13.2.2 Boehringer Ingelheim Animal Health Business Overview
  • 13.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Introduction
  • 13.2.4 Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2015-2020)
  • 13.2.5 Boehringer Ingelheim Animal Health Recent Development
• 13.3 Ceva Sante Animale
  • 13.3.1 Ceva Sante Animale Company Details
  • 13.3.2 Ceva Sante Animale Business Overview
  • 13.3.3 Ceva Sante Animale OTC Pet Medication Introduction
  • 13.3.4 Ceva Sante Animale Revenue in OTC Pet Medication Business (2015-2020)
  • 13.3.5 Ceva Sante Animale Recent Development
• 13.4 Merck Inc.
  • 13.4.1 Merck Inc. Company Details
  • 13.4.2 Merck Inc. Business Overview
  • 13.4.3 Merck Inc. OTC Pet Medication Introduction
  • 13.4.4 Merck Inc. Revenue in OTC Pet Medication Business (2015-2020)
  • 13.4.5 Merck Inc. Recent Development
• 13.5 Zoetis Inc.
  • 13.5.1 Zoetis Inc. Company Details
  • 13.5.2 Zoetis Inc. Business Overview
  • 13.5.3 Zoetis Inc. OTC Pet Medication Introduction
  • 13.5.4 Zoetis Inc. Revenue in OTC Pet Medication Business (2015-2020)
  • 13.5.5 Zoetis Inc. Recent Development
• 13.6 Elanco
  • 13.6.1 Elanco Company Details
  • 13.6.2 Elanco Business Overview
  • 13.6.3 Elanco OTC Pet Medication Introduction
  • 13.6.4 Elanco Revenue in OTC Pet Medication Business (2015-2020)
  • 13.6.5 Elanco Recent Development
• 13.7 Virbac SA
  • 13.7.1 Virbac SA Company Details
  • 13.7.2 Virbac SA Business Overview
  • 13.7.3 Virbac SA OTC Pet Medication Introduction
  • 13.7.4 Virbac SA Revenue in OTC Pet Medication Business (2015-2020)
  • 13.7.5 Virbac SA Recent Development
• 13.8 Vetoquinol SA
  • 13.8.1 Vetoquinol SA Company Details
  • 13.8.2 Vetoquinol SA Business Overview
  • 13.8.3 Vetoquinol SA OTC Pet Medication Introduction
  • 13.8.4 Vetoquinol SA Revenue in OTC Pet Medication Business (2015-2020)
  • 13.8.5 Vetoquinol SA Recent Development
• 13.9 Frontline
  • 13.9.1 Frontline Company Details
  • 13.9.2 Frontline Business Overview
  • 13.9.3 Frontline OTC Pet Medication Introduction
  • 13.9.4 Frontline Revenue in OTC Pet Medication Business (2015-2020)
  • 13.9.5 Frontline Recent Development
• 13.10 Zymox
  • 13.10.1 Zymox Company Details
  • 13.10.2 Zymox Business Overview
  • 13.10.3 Zymox OTC Pet Medication Introduction
  • 13.10.4 Zymox Revenue in OTC Pet Medication Business (2015-2020)
  • 13.10.5 Zymox Recent Development
• 13.11 ChloraSeb
  • 10.11.1 ChloraSeb Company Details
  • 10.11.2 ChloraSeb Business Overview
  • 10.11.3 ChloraSeb OTC Pet Medication Introduction
  • 10.11.4 ChloraSeb Revenue in OTC Pet Medication Business (2015-2020)
  • 10.11.5 ChloraSeb Recent Development
• 13.12 Sulfox
  • 10.12.1 Sulfox Company Details
  • 10.12.2 Sulfox Business Overview
  • 10.12.3 Sulfox OTC Pet Medication Introduction
  • 10.12.4 Sulfox Revenue in OTC Pet Medication Business (2015-2020)
  • 10.12.5 Sulfox Recent Development
• 13.13 Adequan
  • 10.13.1 Adequan Company Details
  • 10.13.2 Adequan Business Overview
  • 10.13.3 Adequan OTC Pet Medication Introduction
  • 10.13.4 Adequan Revenue in OTC Pet Medication Business (2015-2020)
  • 10.13.5 Adequan Recent Development
• 13.14 Dechra Pharmaceuticals PLC
  • 10.14.1 Dechra Pharmaceuticals PLC Company Details
  • 10.14.2 Dechra Pharmaceuticals PLC Business Overview
  • 10.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Introduction
  • 10.14.4 Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2015-2020)
  • 10.14.5 Dechra Pharmaceuticals PLC Recent Development
• 13.15 Nutramax Laboratories, Inc.
  • 10.15.1 Nutramax Laboratories, Inc. Company Details
  • 10.15.2 Nutramax Laboratories, Inc. Business Overview
  • 10.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Introduction
  • 10.15.4 Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2015-2020)
  • 10.15.5 Nutramax Laboratories, Inc. Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer